T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirements
July 31, 2023 08:30 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems to Attend Upcoming Investor Conferences
July 28, 2023 08:30 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 28, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems to Report Second Quarter 2023 Financial Results on August 7, 2023
July 24, 2023 16:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that...
T2 Biosystems Reports Granting of Inducement Award
July 21, 2023 16:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 21, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to...
T2 Biosystems Receives FDA Breakthrough Device Designation for Candida Auris Diagnostic Test
July 20, 2023 08:30 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today...
T2 Biosystems Announces Preliminary Second Quarter 2023 Financial Results
July 12, 2023 08:30 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces Conversion of Approximately Twenty Percent of CRG Term Loan into Equity
July 06, 2023 08:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., July 06, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces Clinical Collaboration with Vanderbilt University Medical Center to Implement and Evaluate the T2Bacteria Panel for Clinical Use
June 09, 2023 09:15 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., June 09, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced a...
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for Candida Auris Diagnostic Test
June 05, 2023 09:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Announces Second Largest Sepsis-Driven Instrument Sale in Company History
May 30, 2023 09:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the...